News

As part of the agreement, CSafe RKN will be added to Kuehne + Nagel’s health care product portfolio. Csafe president Brian Kohr said Csafe is happy to provide

DiFusion’s CleanFUZE has completed a series of in vivo and in vitro clinical tests, which showed that it could eradicate 99.998% of methicillin-resistant staphylococcus aureus bacteria and prevent

The randomised, double-blind Phase 2 study is designed to determine the safety and efficacy profile of TCN-032 in normal volunteers challenged with influenza A. All the subjects in

Under the strategic alliance, both the companies will offer contract development and manufacturing of ADCs by simplifying the supply chain and vendor management relationships. Fujifilm Diosynth Biotechnologies commercial

Hokusai-VTE Phase 3 study, which enrolled more than 8,250 patients from more than 400 clinical sites, will compare Edoxaban 60mg once-daily to warfarin control therapy. The double-dummy, event-driven,

Kerala State Health Department official was quoted by Pharmabiz as saying that detailed modalities were being worked out and feasibility studies were being done to set drug plants.

Taibang with the GMP certificate, expects to commence commercial manufacturing of FVIII products, which are used to treat hemophilia A. The subsidiary is also considering to construct an

The 66,000ft² plant, which will increase the production capacity to more than double, will produce nutritional bars like MET-Rx, Pure Protein and Good ‘n Natural. NBTY CEO Jeff

Infusion Sciences Founder and Youth Infusion developer Budge Collinson said The Vitamin Shoppe is a better partner to carry Youth Infusion. "A huge part of the population has difficulty swallowing pills,"